Informações:
Falhas:
ID
21870
Descrição
Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00411528
Link
https://clinicaltrials.gov/show/NCT00411528
Palavras-chave
Versões (1)
- 05/05/2017 05/05/2017 -
Transferido a
5 de maio de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Metastatic Hormone Refractory Prostate Cancer DRKS00007583 NCT00411528
Eligibility Metastatic Hormone Refractory Prostate Cancer NCT00411528
- StudyEvent: Eligibility
Similar models
Eligibility Metastatic Hormone Refractory Prostate Cancer NCT00411528
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Age
Item
must be ≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
Prostate carcinoma
Item
confirmed and documented diagnosis of prostate cancer
boolean
C0600139 (UMLS CUI [1])
Disease Progression Evidence of | Hormone refractory prostate cancer
Item
confirmed and documented evidence of progression of disease (hormone refractory)
boolean
C0242656 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C1328504 (UMLS CUI [2])
C0332120 (UMLS CUI [1,2])
C1328504 (UMLS CUI [2])
Low testosterone levels
Item
low testosterone levels
boolean
C4011625 (UMLS CUI [1])
Chemotherapy naive
Item
chemotherapy-naïve
boolean
C0392920 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0919936 (UMLS CUI [1,2])
Therapeutic radiology procedure
Item
recent radiation therapy (within 4 weeks)
boolean
C1522449 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
known brain metastasis
boolean
C0220650 (UMLS CUI [1])
Peripheral Neuropathy
Item
peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
Diarrhea
Item
active diarrhea
boolean
C0011991 (UMLS CUI [1])
Illness | Heart Disease | Diabetes Mellitus | Communicable Diseases chronic | Communicable Diseases Uncontrolled
Item
significant illnesses such as heart disease, diabetes, or chronic or uncontrolled infections
boolean
C0221423 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0011849 (UMLS CUI [3])
C0009450 (UMLS CUI [4,1])
C0205191 (UMLS CUI [4,2])
C0009450 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
C0018799 (UMLS CUI [2])
C0011849 (UMLS CUI [3])
C0009450 (UMLS CUI [4,1])
C0205191 (UMLS CUI [4,2])
C0009450 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
Allergic Reaction epothilone B | Allergic Reaction docetaxel | Prednisone allergy | Allergic Reaction Compound Similar
Item
allergic reactions to patupilone or docetaxel or prednisone or similar compounds
boolean
C1527304 (UMLS CUI [1,1])
C0297960 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C0246415 (UMLS CUI [2,2])
C0571591 (UMLS CUI [3])
C1527304 (UMLS CUI [4,1])
C1706082 (UMLS CUI [4,2])
C2348205 (UMLS CUI [4,3])
C0297960 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C0246415 (UMLS CUI [2,2])
C0571591 (UMLS CUI [3])
C1527304 (UMLS CUI [4,1])
C1706082 (UMLS CUI [4,2])
C2348205 (UMLS CUI [4,3])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])